Global Forum on Nicotine (GFN) 2018 Jun 14, 2018 20180614 Jun 16, 2018 Warsaw, Poland The theme for the conference is ‘Rethinking Nicotine’. The organizers believe that this reflects the appetite that now exists to examine the changing methods and patterns of use, along with the emerging science relating to nicotine. Reflecting on what has been discussed and taking into account the feedback received from participants, the choice of the theme for GFN 18 enables both for reflection, as well as some projection, concerning the use and potential for nicotine in the future. Once again the International Symposium on Nicotine Technology (ISoNTech) will run alongside GFN 18. This public event will be structured as a ‘show and tell’ where developers and manufacturers of new devices and products can demonstrate and discuss the science and technology behind them. /content/dam/pmiscience/default-fallback-thumbnails/conference/pmi-science-conferences-image.png

      Global Forum on Nicotine (GFN) 2018

      Date
      Jun 14, 2018 - Jun 16, 2018
      Location
      Warsaw, Poland
      The theme for the conference is ‘Rethinking Nicotine’. The organizers believe that this reflects the appetite that now exists to examine the changing methods and patterns of use, along with the emerging science relating to nicotine. Reflecting on what has been discussed and taking into account the feedback received from participants, the choice of the theme for GFN 18 enables both for reflection, as well as some projection, concerning the use and potential for nicotine in the future. Once again the International Symposium on Nicotine Technology (ISoNTech) will run alongside GFN 18. This public event will be structured as a ‘show and tell’ where developers and manufacturers of new devices and products can demonstrate and discuss the science and technology behind them.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.